Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Secondary Databased Post-marketing Surveillance Study of BNT162b2

NCT06743334 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06743334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06743334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Secondary Databased Post-marketing Surveillance Study of BNT162b2
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
April 23, 2025
Completion date
May 28, 2025
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2